{"disease":{"id":"neurotrophic-keratitis","name":"Neurotrophic keratitis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"cenegermin","indication_name":"Neurotrophic keratitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Oxervate","generic_name":"CENEGERMIN","company_name":"Dompe farmaceutici s.p.a.","drug_phase":"marketed","molecular_target":"High affinity nerve growth factor receptor","drug_class":"Recombinant Human Nerve Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":"Oxervate works by binding to the high affinity nerve growth factor receptor to stimulate nerve growth and repair."},{"drug_id":"cenegermin","indication_name":"Neurotrophic keratitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Oxervate","generic_name":"CENEGERMIN","company_name":"Dompe farmaceutici s.p.a.","drug_phase":"marketed","molecular_target":"High affinity nerve growth factor receptor","drug_class":"Recombinant Human Nerve Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":"Oxervate works by binding to the high affinity nerve growth factor receptor to stimulate nerve growth and repair."},{"drug_id":"cenegermin-bkbj","indication_name":"Neurotrophic keratitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Oxervate","generic_name":"Cenegermin-Bkbj","company_name":"Dompe farmaceutici s.p.a.","drug_phase":"marketed","molecular_target":"High affinity nerve growth factor receptor","drug_class":"Recombinant Human Nerve Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":"Oxervate works by mimicking the natural nerve growth factor to stimulate nerve regeneration and promote healing in the cornea."},{"drug_id":"oxervate","indication_name":"Neurotrophic keratitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Oxervate","company_name":"Dompé Farmaceutici S.p.A","drug_phase":"marketed","molecular_target":"High affinity nerve growth factor receptor, Tumor necrosis factor receptor superfamily member 16","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04909450","title":"Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Claris Biotherapeutics, Inc.","has_results":false},{"nct_id":"NCT04276558","title":"REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"RECORDATI GROUP","has_results":true},{"nct_id":"NCT05758753","title":"QST for Corneal Nerve Function","phase":"NA","overall_status":"SUSPENDED","enrollment_count":108,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT06597422","title":"A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Staidson (Beijing) Biopharmaceuticals Co., Ltd","has_results":false},{"nct_id":"NCT05566717","title":"An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Medical Center Ophthalmology Associates","has_results":false},{"nct_id":"NCT04485546","title":"Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Dompé Farmaceutici S.p.A","has_results":true},{"nct_id":"NCT05552261","title":"DEFENDO Long Term Follow-up Study in Stage 1 NK Patients","phase":"","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Dompé Farmaceutici S.p.A","has_results":true},{"nct_id":"NCT04820010","title":"Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.","has_results":false},{"nct_id":"NCT06964269","title":"Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Toyos Clinic","has_results":false},{"nct_id":"NCT06364657","title":"Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye","phase":"","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05927428","title":"Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"BRIM Biotechnology Inc.","has_results":false},{"nct_id":"NCT07073729","title":"Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT04573647","title":"OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate","phase":"","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Sight Medical Doctors PLLC","has_results":false},{"nct_id":"NCT06947850","title":"DOMPE -MT Neurotrophic Keratitis","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Toyos Clinic","has_results":false},{"nct_id":"NCT04627571","title":"Corneal Nerves After Treatment With Cenegermin","phase":"","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04552730","title":"Nerve Growth Factor for the Treatment of Cornea Disease","phase":"","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT05809245","title":"Corneal Neurotization as a Treatment for Neurotrophic Keratopathy","phase":"NA","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT03037450","title":"Miniinvasive Corneal Neurotization. A Pilot Study.","phase":"NA","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT05321251","title":"Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.","phase":"PHASE2, PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT06411145","title":"Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Dompé Farmaceutici S.p.A","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}